Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Cumberland Pharmaceuticals Inc changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 31 | 30 | −1 |
| Shares | 3.68M | 3.41M | −275.2K (−7.5%) |
| Value | $12.3M | $10.6M | −$1.70M (−13.8%) |
New holders (3)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jones Financial Companies LLLP | 600 | $1.85K | 0.00% |
| Farther Finance Advisors, LLC | 345 | $1.08K | 0.00% |
| Citigroup Inc | 4 | $12 | 0.00% |
Sold out (4)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Simplex Trading, LLC | 14,218 | $47.0K |
| Susquehanna International Group, LLP | 11,527 | $38.6K |
| Wiley Bros.-Aintree Capital, LLC | 11,000 | $36.9K |
| Barclays PLC | 2 | $7 |